ArticleLa Radiologia medica2026
Optimizing MRI sequence selection for glioma classification: a radiomics-based analysis of WHO CNS grade, final pathological diagnosis, and IDH status.
Article in La Radiologia medica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundMulti-sequence MRI protocols for glioma classification are resource-intensive, prompting the need to identify optimal, potentially reduced imaging protocols. PURPOSE: To evaluate the diagnostic utility of individual MRI sequences (ASL, DWI, FLAIR, SWI, T1w, T2w) for classifying WHO CNS grade (II, III, IV), final pathological diagnosis (glioblastoma vs. astrocytoma), and IDH status (mutated, wildtype, IDH1) using radiomic features and machine learning. MATERIALS AND
methodsWe analyzed data from 501 patients with diagnosed brain cancer from the UCSF-PDGM dataset, by extracting radiomics features from all available imaging sequences and training uni- and multi-sequence machine learning models (ASL, DWI, FLAIR, SWI, T1w, T2w) for the three outcome tasks of interest. Performance metrics (accuracy, sensitivity, F1-score) were derived for each task, alongside feature selection frequencies.
resultsThe uni-sequence machine learning models using FLAIR imaging features excelled for WHO CNS grade classification (57.4% accuracy), ASL for final pathological diagnosis (81.5% accuracy), and T1w for IDH status classification (66.7% accuracy). Interestingly, the combination of all sequences did not lead to significant improvements compared to the best performing uni-sequence machine learning models for the three tasks. Regardless of the input sequence, the models consistently relied on similar features, such as shape and demographic variables (e.g., patient age and tumor sphericity).
conclusionSingle sequences, such as FLAIR, ASL, and T1w, achieved the highest individual accuracies in the radiomics models for classification of tumor grade, final diagnosis, and IDH status, and may inform the design of more streamlined imaging protocols.
Indexed as
Identifiers
42701952What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.